Protective Effect of Valsartan on Podocyte Injury in Rats with Diabetic Nephropathy [PDF]
Qingfen Wang
openalex +1 more source
Efficacy and safety of sacubitril/valsartan combined with dapagliflozin in non-diabetic patients with advanced chronic kidney disease. [PDF]
Wang H, Li X, Jiang C, Liu X.
europepmc +1 more source
The Effect of Sacubitril/Valsartan on Mood and Cognitive Function in Patients with Heart Failure with Reduced Ejection Fraction. [PDF]
Al Kindi F +7 more
europepmc +1 more source
Effects of Sacubitril/Valsartan on Blood Pressure and Proteinuria in Hypertensive Patients With Chronic Kidney Disease [PDF]
Maki Murakoshi +5 more
openalex +1 more source
Sacubitril/valsartan as add-on to standard therapy in patients with heart failure: A randomized controlled trial. [PDF]
Dhawan R +6 more
europepmc +1 more source
The Cost-Effectiveness of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure with Reduced Ejection Fraction in England and Scotland: Applying Real-World Evidence to Enhance Generalisability to A UK Population [PDF]
David Trueman +8 more
openalex +1 more source
Early Initiation of Sacubitril/Valsartan in Intracerebral Hemorrhage With Refractory Hypertension and Chronic Heart Failure: A Case Report. [PDF]
Nishino T +4 more
europepmc +1 more source
Pharmacokinetic and bioequivalence of two formulations of Valsartan/Amlodipine Tablet(I) in healthy Chinese volunteers: A randomized, three-period, partially replicated crossover study. [PDF]
Mei Y, Zuo X, Zhang T, Bu Z, Xu Z.
europepmc +1 more source

